Atricure reports fourth quarter 2020 and full year 2020 financial results

Mason, ohio--(business wire)--atricure, inc. (nasdaq: atrc), a leading innovator in treatments for atrial fibrillation (afib) and left atrial appendage (laa) management, today announced fourth quarter 2020 and full year 2020 financial results. “despite challenges posed in 2020 as a result of the pandemic, we made meaningful progress across our business with our strategic initiatives,” said michael carrel, president and chief executive officer of atricure. “looking ahead to 2021 and beyond, we a
ATRC Ratings Summary
ATRC Quant Ranking